I've added substantially from .04 flat all the way to our lowest .02's. A couple million shares. I believe that absent the resistance covid created, both with delayed trials and the Sungen deal falling apart, that going forward we should be able to gain some traction where for a time we seemed to tread water at best. Also, Elite makes a good product in their Adderal generics. Couple that with the ongoing shortage issues, and now having the opportunity to sell it on our own....well, I feel as though the potential for larger revenues/profitabilty is there. I liked Nasrat's assertiveness in hiring Kirkov, and also took notice in his interest in marketing products outside of the United States, something big daddy K knows all about. All of this doesn't even include any new products under development. Lot's of upside potential, imo.
News 
Market Data 
Discover 
AI
